Study of Orally Administered AG-120 in Subjects With Advanced Solid Tumors, Including Glioma, With an IDH1 Mutation

NCT02073994 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

174

Enrollment

OTHER

Sponsor class

Conditions

Cholangiocarcinoma
Chondrosarcoma
Glioma
Other Advanced Solid Tumors

Interventions

DRUG: AG-120

Sponsor

Institut de Recherches Internationales Servier